Rapid test for gonorrhoea and chlamydia receives $1.8m backing

CARB-X is awarding SpeeDx, a diagnostics company in Sydney, Australia, up to $1.8 million to develop a rapid test for Chlamydia trachomatis and Neisseria gonorrhoeae, sexually transmitted bacteria that can cause serious infections.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: